What To Know
- This patent will be utilized to create implants that match the patient's specific bone density based on a DEXA Scan/T-score allowing for the best bone fusion treatment and most favorable outcome based on that patient's bone density.
- Aurora Spine notes their first-of-its kind DEXA Technology™ is designed to match a patient's bone density, promote bone in-growth while maintaining the biomechanical structure and bone support.
October 6, 2020
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 10,779,954 entitled “Body Density Scan Result-Matched Orthopedic Implants and Methods of Use” for The World’s First DEXA Technology™ Patient-Matched Implant Technology.
Aurora Spine notes their first-of-its kind DEXA Technology™ is designed to match a patient’s bone density, promote bone in-growth while maintaining the biomechanical structure and bone support. This patent will be utilized to create implants that match the patient’s specific bone density based on a DEXA Scan/T-score allowing for the best bone fusion treatment and most favorable outcome based on that patient’s bone density.
Aurora Spine’s DEXA Technology™ is part of the company’s advanced portfolio representing the future of Spinal and Orthopedic implants. Following fundamental principles of patent focused innovation, DEXA Technology™ was logically created and patented to combine the essential design benefits of conventional machining, 3D printing, and additive implant manufacturing.
“Aurora Spine’s new DEXA Technology™ will provide surgeons with additional solutions in selecting the right implant for their patient,” said Trent Northcutt, CEO of Aurora Spine. “The DEXA opportunity represents our continued commitment to delivering best-in-class implants that enable our surgeon partners to overcome common osteoporosis challenges faced in traditional procedures. We will be commercializing this technology in the coming months.”
Laszlo Garamszegi, Chief Technology Officer of Aurora Spine, added “Traditionally, medical devices for spinal procedures are designed as ‘one size fits all’ and assumes that every patient’s bone density is similar. The proprietary engineering behind our DEXA Technology™ is advancing the science of implant technology, and ultimately helping improve patient fusion rates and overall clinical outcomes.”